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BACKGROUND: Heart transplant programs and regulatory entities require highly accurate performance
metrics to support internal quality improvement activities and national oversight of transplant programs, respectively. We assessed the accuracy of publicly reported performance measures.
METHODS: We used the United Network for Organ Sharing registry to study patients who underwent
heart transplantation between January 1, 2016 and June 30, 2018. We used tests of calibration to compare the observed rate of 1-year graft failure to the expected risk of 1-year graft failure, which was calculated for each recipient using the July 2019 method published by the Scientific Registry of
Transplant Recipients (SRTR). The primary study outcome was the joint test of calibration, which
accounts for both the total number of events predicted (calibration-in-the-large) and dispersion of risk
predictions (calibration slope).
RESULTS: 6,528 heart transplants were analyzed. The primary test of calibration failed (p <0.0001),
indicating poor accuracy of the SRTR model. The calibration-in-the-large statistic (0.63, 95% confidence interval [CI] 0.58-0.68, p < 0.0001) demonstrated overestimation of event rates while the calibration slope statistic (0.56, 95% CI 0.49-0.62, p <0.0001) indicated over-dispersion of event rates.
Pre-specified subgroup analyses demonstrated poor calibration for all subgroups (each p <0.01). After
recalibration, program-level observed/expected ratios increased by a median of 0.14 (p <0.0001).
CONCLUSIONS: Risk models employed for publicly-reported graft survival at U.S. heart transplant centers lack accuracy in general and in all subgroups tested. The use of disease-specific models may
improve the accuracy of program performance metrics.
J Heart Lung Transplant 000;000:1−8
Ó 2021 International Society for Heart and Lung Transplantation. All rights reserved.

Assuring the quality of solid organ transplant programs
is essential to optimizing patient outcomes and maximizing
the utility of scarce donor organs. The duty of maintaining
Abbreviations: O/E, Observed/expected; OPTN, Organ Procurement and
Transplantation Network; SRTR, Scientific Registry of Transplant Recipients; UNOS, United Network for Organ Sharing
Reprint requests: Stephen J. Dolgner, MD, Adult Congenital Heart Program, Texas Children's Hospital, 6651 Main St, Suite E1920, Houston, TX
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quality is largely placed upon transplant centers with mandatory oversight provided by the United Network of Organ
Sharing (UNOS) and the Center for Medicare and Medicaid
Services. The Scientific Registry of Transplant Recipients
(SRTR) generates several measures of center performance
including organ acceptance rates, wait list mortality, graft
failure rates, and patient mortality rates and publicly
reports observed/expected ratios (O/E) for outcomes such
as 1-year graft failure for transplant programs. The quality
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metrics influence center behavior, payor status, and public
perception.
The risk-adjusted performance metrics are generated by
the SRTR using a process with both quantitative and qualitative methods.1 The performance of solid organ transplant
risk adjusting models is typically measured by assessment
of discrimination using concordance statistics (C-statistics). Discrimination refers to how accurately a model can
rank those at high risk vs. lower risk for having an event.2
The accuracy of SRTR heart transplant risk models for
1-year graft failure is demonstrably low and variable,
with C-statistics from 0.67-0.83 for post-transplant outcomes such as graft survival.1,3 In transplant and other
healthcare domains, primary reliance on the C-statistic to
define model performance has demonstrated poor
performance.1,4 Transplant risk models generally utilize
one model with many variables despite the heterogeneity
of diseases, chronicity of disease, quality of donors and
donor-recipient matching characteristics, and this
approach is unlikely to capture the multitude of patients
and donor-recipient matching scenarios encountered in
United States (U.S.) heart transplantation. Further, a
model may perform well in identifying patients with vs.
without events in a large and heterogeneous population,
but the same model could fail to discriminate risk when a
local sample (such as patients at a local transplant center)
is more homogenous.
To truly assess the performance of a risk prediction
model, model calibration must be assessed in addition to
discrimination. Model calibration refers to how well a model’s predicted risk for a particular risk group approximates
the true (i.e. observed) risk.2 In order to accurately calculate
O/E ratios, the risk adjusting models must accurately predict the absolute number of expected events, in addition to
rank ordering the patients correctly. While accuracy cannot
be assured for every recipient, the models should be accurate for large subgroups of patients and those at very high
risk of affecting program outcomes. Collectively, these factors may result in risk-adjustment models that do not accurately predict the absolute risk of events, resulting in
inaccurate measures of center performance.
We hypothesized that the 1-year graft failure model used
for evaluation of heart transplant center performance lacks
accuracy due to 1) unmodeled recipient and donor factors
and 2) lack of validation using measures of model discrimination. The finding of inaccuracies attributable to these factors may guide future modeling efforts designed to increase
the accuracy of publicly reported program performance
metrics, thereby allowing more meaningful quality
improvement activities for transplant programs and accurate oversight by regulatory bodies.

Methods
We tested the hypothesis that the SRTR model for 1-year graft survival is not accurate. One-year graft failure was selected for its primacy in regulatory and public reporting.3,5,6 We tested whether
pre-defined subgroups of patients with uncommon diseases and
selected risk factors that were poorly represented in the heart risk

models may have particularly inaccurate risk estimates of 1-year
graft survival.

Patient selection
We identified adult (≥ 18 years) deceased donor heart transplants
recorded in the UNOS registry transplanted between January 1,
2016 and June 30, 2018. This sample time frame corresponds to
the summer 2019 graft failure models. Multi-organ transplant
recipients were excluded.

Statistical analysis
The observed events were recorded based on the presence or
absence of graft failure at one year. The expected number of
events was calculated directly from the July 2019 Program Specific Report model for each heart transplant recipient (https://
www.srtr.org/reports-tools/posttransplant-outcomes/) using the
coefficients and baseline hazard as determined by the SRTR. This
model accounts for all of the variables in Table S1 and results in a
single predicted event rate for each patient based on individual
recipient and donor risk factors. To minimize the effect of censoring related to the differential lengths of follow up between groups,
we calculated the number of expected events for each patient
based on an anticipated 1 year follow up time as could be done
with the SRTR model at the time of transplantation; this resulted
in all of the expected event rates having a uniform length of follow
up for analysis. Mean study follow up was 361.5 days per patient.
The primary hypothesis was tested using a joint probability test
derived from an overall test of calibration-in-the-large and calibration slope using Poisson regression according to the methods
reported by Therneau, Royston and Steyerberg.7-9 The model was
considered poorly calibrated if the calibration-in-the-large and the
unitless calibration slope deviated significantly from 1. Further
examination of the source of calibration error was derived from
isolated tests of calibration. Calibration-in-the-large was obtained
from a model with the intercept estimated and a fixed linear predictor slope. Calibration slope was obtained from a model with a
coefficient for the linear predictor and a fixed intercept. See Supplemental Code for complete details. Visual estimates of calibration were made by plotting deciles of predicted risk versus
observed graft failure rates within deciles defined by the risk estimates. Visual analysis of calibration demonstrated poor calibration at high predicted event rates and prompted analysis of outliers
as the source of miscalibration. As a sensitivity analysis, subjects
with an estimated risk >1 had their risk estimate assigned as one,
and the pre-specified tests of the primary hypothesis were repeated
under this condition. We did not refit the SRTR coefficients or
baseline hazard to the sample model during any phase of the calibration assessment.
The secondary hypotheses were tested by restricting the sample
to the group under evaluation and repeating the primary hypothesis test procedure. Variables for subgroup testing were determined
by the authors using the following criteria: 1) at least moderate
misspecification for a large number of individuals, or 2) a large
degree of misspecification for a small number of individuals. The
final list included recipients with ventricular assist device (VAD)
support, diagnosis of adult congenital heart disease (ACHD),
retransplants, and recipients aged ≥65 years.
To demonstrate the magnitude of miscalibration by center, we
recalibrated the SRTR model by including terms for all factors
pre-specified for secondary analyses, including terms for both the
expected number of events and the square of expected events to
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Table 1 Demographics and Clinical Characteristics of Heart
Transplant Recipients. Categorical Variables are Reported as n
(%). Continuous Variables are Reported as Median (IQR).
Number of transplants
Number of centers
Annual center volume
Age
Gender
Female
Male
Race/Ethnicity
White
Black
Hispanic
Asian
American Indian/Alaska native
Native Hawaiian/pacific islander
Multiracial
Height (cm)
Weight (kg)
One year graft failure

6,528
126
18 (9, 29)
57 (47, 63)
1747 (26.7)
4781 (73.2)
4191 (64.2)
1453 (22.3)
579 (8.9)
219 (3.4)
19 (0.3)
30 (0.5)
37 (0.6)
175 (168, 180)
83 (71, 97)
576 (8.8)
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ratios and recalibrated O/E ratios were plotted on a density plot by
center and differences between models were estimated using the
signed rank test. Centers with zero events were excluded from the
re-calibration analyses.
Two-sided p-values less than 0.05 were considered statistically significant throughout the analysis. Statistical analyses
were carried out with R software, version 3.6.2 (R Project for
Statistical Computing) using the survival and hmisc packages.
The institutional review board of the University of Washington determined that this research did not meet criteria as
human subjects research.
The data reported here have been supplied by the United Network for Organ Sharing as the contractor for the Organ Procurement and Transplantation Network (OPTN). The interpretation
and reporting of these data are the responsibility of the authors
and in no way should be seen as an official policy of or interpretation by the OPTN or the U.S. Government. This analysis is based
on OPTN data as of September 1, 2019, which includes outcome
data through June 2019.

Results
normalize nonlinear relationships between predicted and observed
event rates, and capping the number of expected events to 1 for
each subject. The recalibrated expected event rates were used to
generate new O/E ratios for each center. The existing model O/E

We identified a total of 6,528 heart transplants in the
specified time interval (Table 1) representing transplants at 126 transplant centers. Annual center volume
was highly variable. The one-year graft failure rate was
8.8%.

Figure 1
Calibration plots comparing observed and expected graft failure events for the heart transplant model stratified by deciles.
Inset plots show full scale.
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<0.0001
<0.0001
0.0034
<0.0001
<0.0001
0.56 (0.49, 0.62)
0.60 (0.51, 0.69)
0.63 (0.37, 0.88)
0.42 (0.18, 0.65)
0.54 (0.41, 0.68)
<0.0001
<0.0001
0.0015
0.0005
<0.0001
0.63 (0.58, 0.68)
0.69 (0.62, 0.77)
0.52 (0.34, 0.78)
0.47 (0.31, 0.72)
0.71 (0.61, 0.83)
<0.0001
<0.0001
0.0017
<0.0001
<0.0001

A calibration plot (Figure 1) demonstrated reasonable
visual calibration except for the highest risk decile, where
risk was significantly overestimated. Complete decile information is shown in Table S2. The heart transplant one-year
graft survival model failed the joint probability test of calibration (p -value <0.0001) suggesting poor calibration
(Table 2). The number of expected events exceeded 1 in 26
patients; sensitivity analysis obtained by capping expected
events at 1 per patient improved overall calibration, albeit
with continued failure to calibrate (p = 0.0089) as measured
by the joint test of calibration. Thus, predicted event rates
over 1 were not the sole source of calibration error.
The predicted one-year graft failure rate was 14.0%
(916.7 predicted events/6528 patients). Calibration-in-thelarge (synonymous with observed/expected ratio) demonstrated systematic overestimation of model-predicted event
rates (calibration-in-the-large 0.63, 95% Confidence Interval [CI] 0.58-0.68, p <0.0001). Calibration slope measures
dispersion of predicted probabilities, with slopes greater
than 1 indicating too little spread (predictions “do not vary
enough”) and slopes less than 1 indicating too much spread
(predictions “vary too much”).10 The unitless calibration
slope for the overall sample was 0.56 (95% CI 0.49-0.62, p
<0.0001), suggesting that low event rate predictions were
too low and high event rate predictions were too high.
Tests of calibration among subgroups demonstrated that
all pre-specified subgroups were poorly calibrated using the
overall calibration test (Table 2). Calibration-in-the-large
and calibration slope were less than 1 for all subgroups
assessed, suggesting overestimation of event rates and predictions that were too extreme.

576
307
23
22
164

916.7
445.0
44.6
46.5
231.5

Effect of recalibration on observed/expected event
rates

6528
3328
178
134
1362

Calibration in
the large - P-value
Calibration-in-the-large
(95% CI)
Overall P-value
Expected Events
Observed Events
N

Calibration measurements

Overall
VAD
ACHD
Previous transplant
Over age 65

Table 2

Measures of Calibration Overall and for Pre-Specified Subgroups. VAD, ventricular assist device; ACHD, adult congenital heart disease.

Calibration slope
(95% CI)

Calibration
slope - P-value
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Recalibrated event rates were derived from a nonlinear
model using the pre-specified subgroups. Aggregating individual results to centers demonstrated movement of median
O/E ratios toward 1.0 and were most consistent with the
direction of miscalibration suggested by calibration-in-thelarge results (Figure 2). Accordingly, center-level
observed/expected ratios increased (median O/E difference
0.14, p <0.0001). The changes between existing and recalibrated O/E ratios by center volume are depicted in Figure 3,
and the number of expected events in the existing model
versus the recalibrated model for each center is shown in
Figure 4. While some programs had a decrease in their O/E
ratio with recalibration (blue arrows in Figure 3), the majority of programs, including low, medium, and high volume
programs, had an increase in their O/E ratio (red arrows in
Figure 3).

Discussion
Heart transplant recipients are diverse in demographics,
type of disease, severity of illness, immunological risk, and
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Figure 2
Density plots of observed/expected ratios at the center level in the existing and recalibrated models for heart transplant recipients. Vertical red and blue lines represent median O/E ratios for existing and recalibrated models, respectively.

Figure 3
Change in center observed/expected ratio between existing and recalibrated heart transplant models, compared by annual center volume. Observed/Expected ratio capped at 5 for graphical display purposes.
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Figure 4
Number of expected events per center in the existing model and recalibrated models for heart transplant recipients, stratified by
annual center volume quintile.

quality of donors and skill of the managing medical and surgical teams. The models used to assess center performance
must accurately adjust for the wide spectrum of recipient
and donor diversity in order to infer the quality of transplant
centers. We demonstrate that the accuracy of the adjusting
model used for assessing the performance of heart transplant programs was suboptimal for one-year graft failure
and did not fit any of the pre-specified subgroups tested.
Thus, the models were not accurate overall, nor for any of
the pre-specified recipient subgroups. This finding suggests
that risk adjustment modeling for heart transplant can be
improved by general recalibration and disease-specific
modeling and that remediable inaccuracies in publicly
reported program performance likely exist. The present
findings have important implications for programs’ ability
to benchmark and improve performance, as well as for regulatory oversight activity, including scrutiny and penalties.
Patients, payors, U.S. regulatory bodies and centers use
publicly reported metrics to make judgments about where
to seek heart transplant in the U.S., how to determine payment, which centers should be flagged for under-performance, and where to focus efforts for program
improvement. Performance metrics may create unintended
incentives to avoid transplant in high-risk patients or discard high-risk donors, behaviors which have been demonstrated in other fields of cardiology and cardiac surgery.1116
Paradoxically, if the high risk features are accurately

accounted for in the risk model, these same behaviors actually worsen center performance metrics. Previous research
in kidney transplantation has suggested donor quality metrics may or may not influence specific decisions regarding
transplant and donor selection.17,18 The present study evaluates model accuracy in great detail according to the published method used to generate program specific reports
and identifies significant inaccuracy that extend to the level
of program performance measures. In identifying inaccuracy, the present research also identifies several remedies
that may improve the accuracy of risk models and, subsequently, improve confidence in the use of risk-adjusted metrics as reflections of the true quality of transplant programs.
We demonstrate that risk adjustment models for assessing one-year graft failure in the U.S. are poorly calibrated.
These errors may be caused by small numbers of recipients
with diverse diseases, use of rank-order statistics as measures of risk model accuracy, miscalibration of the baseline
event rate, misspecification of variables in the model, interactions that are not currently specified in the model, and/or
allowing the number of events to be greater than 1 for an
individual recipient. While the SRTR process for model
derivation is likely to generate accurate models, our results
suggest that additional steps may be necessary to ultimately
assure generation of accurate O/E metrics. Thus, our investigation finds that heart transplant risk adjustment models
used to generate publicly reported metrics in the U.S. do
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not make accurate predictions. Herein, we suggest two
potential sources for improving future risk adjustment models: the use of calibration methods during model derivation
and the use of disease-specific models.
This investigation was motivated by the notion that
groups of patients with rare diseases or at the extremes
of clinical stability at the time of transplant may have
inappropriately low or high risk assigned as the result of
under-representation in the heart transplant population.
Previous studies have shown that subgroups of patients
appear to have differently shaped survival curves. 19
Thus, the use of a single model with a baseline event
rate shared among all recipients - regardless of disease
state or severity - is one source of poor calibration. Our
results demonstrate that many groups of heart transplant
recipients had inaccurate expected event rate predictions, which suggests that efforts to include increasingly
detailed measures of disease-specific post-transplant
survival may improve the accuracy of risk models. Specifically, early mortality has been shown to be increased
for patients with hypertrophic/restrictive cardiomyopathy and congenital heart disease.19,20 While models cannot accurately predict event rates for every disease, the
present results suggest that more accurate estimates of
risk within select subgroups are achievable.
Measures of discrimination, the ability of a model to
assign a higher score to those patients more likely to
have an outcome, are often used to assess model accuracy
when only measures of calibration are appropriate. Measures of discrimination are currently used to assess the
accuracy of all solid organ graft failure models.1,3 While
calibration plots are used to evaluate calibration, these
plots necessarily aggregate data and model-based calibration tests may identify severe errors of calibration not
apparent from graphical analysis alone.7 Prior research in
solid organ transplantation also suggests that measures of
discrimination have little relationship to performance.5
Observed/expected ratios are dependent on accurate estimation of expected events, which require absolute predictions to be correct. We demonstrate that calibration
frequently fails for the heart risk adjustment model. The
present results suggest that implementation of calibration
metrics at the time of model development or inclusion of
a calibration step after modeling may be warranted to
improve risk model performance. In addition, individuals
risk predictions should not exceed 1 event per patient and
a maximum cap of 1 event per patient will prevent overestimation of expected event rates within centers. Thus,
the present results suggest that model derivation should
be guided by measures of calibration and predicted event
rates should be capped.
This study has limitations. We calculated risk according to the methods and model components made publicly available by the SRTR. While we reproduced the
SRTR methodology with the highest fidelity, important
details of model creation and application may not be
publicly available. The present results are consistent
with previous reports of low accuracy of risk adjusting
models for kidney transplantation.

7

Conclusions
Models used to assess one-year graft failure risk among
heart transplants failed to demonstrate accurate calibration.
The accuracy of risk-adjusting models used to quantify center performance may be increased by modeling select subgroups of recipients, using measures of calibration in
derivation and validation steps of risk model design, and
capping expected predicted event rates to 1 failure per person. More accurate center performance measures may allow
for more meaningful quality improvement activities and
regulatory oversight in heart transplantation.
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